Clotild introduces an innovative device designed to revolutionize stroke treatment. By integrating the world's smallest impedance meter into a probe, it enables precise identification of clot types, allowing for more effective and efficient removal. Led by CEO France Bojack, this French project aims to reduce the trial and error in stroke treatment, enhancing patient outcomes and reducing healthcare costs. more - https://www.youtube.com/watch?v=0n8NzXt9V0A

Basic information

Country

FRANCE

Group Name

Sensome

Source

Source